
51 - 200 employees
🧬 Biotechnology
💊 Pharmaceuticals
⚕️ Healthcare Insurance
Biotechnology • Pharmaceuticals • Healthcare Insurance
Krystal Biotech, Inc. is a commercial-stage company focused on developing genetic medicines to address high unmet medical needs. Their mission is to develop and deliver redosable gene therapies for the treatment of severe, life-threatening, or rare diseases that have limited or no approved therapies. Krystal's first commercial product, VYJUVEK, is the pioneering redosable gene therapy designed to treat dystrophic epidermolysis bullosa. The company is advancing an integrated pipeline of genetic therapies aimed at correcting the root causes of serious and rare genetic diseases. Krystal utilizes a novel therapeutic platform based on a modified and engineered HSV-1 vector that is replication-defective and non-integrating, ensuring a safe and effective delivery of gene therapies. With two GMP facilities, Krystal is committed to the manufacturing and commercialization of transformative genetic medicines.
🕒 6 days ago
Bilingual Patient Access Liaison providing reimbursement and non-medical educational support to patients in the U.S. Collaborating with HCP staff and caregivers while optimizing therapy adherence.
🗣️🇪🇸 Spanish Required
🕒 June 24
Regional Gene Therapy Liaison promoting Vyjuvek for dystrophic epidermolysis bullosa treatment. Focusing on market development and building healthcare professional relationships in assigned territories.